Submitted by Lucy Rush on Tue, 29/10/2024 - 09:19
Many congratulations to Tom Mitchell who has been appointed as the Krishnan-Ang Distinguished Group Leader in the Urological Malignancies Virtual Institute (UMVI). His appointment is funded through a generous donation by the Krishnan-Ang Foundation to Trinity College.
Tom is an Honorary Consultant Urologist and Clinician Scientist based in Addenbrooke’s Hospital and the Early Cancer Institute. His research aims to improve outcomes for patients with kidney cancer. He has a track record for excellent basic science work in kidney cancer and his current research includes identifying new drivers in kidney cancer and using cutting edge spatial transcriptomic techniques to classify tumours and to understand tissue response to systemic therapy.
Tom said: "The appointment will allow me to answer some of the many unmet needs of the patients I treat at Addenbrooke’s Hospital. To that end, I will establish a world-class, collaborative, and multi-disciplinary team within the Early Cancer Institute.
"We will better understand the behaviour of localised kidney cancer, to discover routes to prevention, and predict the future behaviour of established tumours to enact prompt comprehensive therapy of high-risk tumours and avoid unnecessary interventions to more indolent tumours.”
Brent O’Carrigan, co-lead UMVI said: “Tom is an outstanding scholar and clinician scientist who brings a focus on clinical excellence, academic collaborations and commitment to nurturing talent within his new group to the UM Virtual Institute.”
Grant Stewart, co-lead UMVI added: “Tom brings world leading expertise in the genomics of kidney cancer to strengthen the scientific foundations of the UM Virtual Institute, with a particular focus understanding the genetic drivers of early-stage kidney cancer. He has strong collaborations across the globe with a history of high impact research publications.”